Jay R. Luly
2022
Compensation breakdown
| Non-Equity Incentive Plan | $483,032 |
|---|---|
| Option Awards | $3,739,269 |
| Salary | $725,050 |
| Stock Awards | $2,305,881 |
| Other | $19,424 |
| Total | $7,272,656 |
Luly received $3.7M in option awards, accounting for 51% of the total pay in 2022.
Luly also received $483K in non-equity incentive plan, $725.1K in salary, $2.3M in stock awards and $19.4K in other compensation.
Rankings
In 2022, Jay R. Luly's compensation ranked 387th out of 5,387 executives tracked by ExecPay. In other words, Luly earned more than 92.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 387 out of 5,387 | 93rd |
Division Manufacturing | 159 out of 2,922 | 95th |
Major group Chemicals And Allied Products | 40 out of 1,304 | 97th |
Industry group Drugs | 29 out of 1,209 | 98th |
Industry Pharmaceutical Preparations | 21 out of 870 | 98th |
Pay ratio
| Jay R. Luly's Pay | $7,272,656 |
|---|---|
| Median Employee's Pay | $249,345 |
| Pay Ratio | 29to 1 |
In 2022, the annual total compensation of Jay R. Luly was $7,272,656.
The annual total compensation of the median employee at Enanta Pharmaceuticals was $249,345.
The ratio of Jay R. Luly's pay to the pay of median employee was therefore 29 to one.
Luly's colleagues
We found four more compensation records of executives who worked with Jay R. Luly at Enanta Pharmaceuticals in 2022.
News
January 20, 2023
January 21, 2022
January 21, 2021
January 17, 2020
January 18, 2019